Ping An Healthcare and Technology Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PANHF research report →
Price Chart
About the company
Ping An Healthcare and Technology Company Limited, along with its associated companies, runs a substantial online healthcare platform throughout the People's Republic of China. The company delivers a broad spectrum of virtual medical services, including online doctor consultations, assistance with hospital referrals and appointment scheduling, arrangement of inpatient stays, and providing expert second opinions. Additionally, it develops consumer-focused healthcare offerings, often presented as bundled packages that integrate services from various healthcare institutions.
- CEO
- Mingke He
- IPO
- 2019
- Employees
- 1,668
- HQ
- Shanghai, CN
Get TickerSpark's AI analysis on PANHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.04B
- P/E
- 25.43
- Fwd P/E
- 5.37
- PEG
- 0.18
- P/S
- 2.20
- P/B
- 1.18
- EV/EBITDA
- 18.71
- Div Yield
- 0.00%
- Gross Margin
- 34.64%
- Op Margin
- 3.21%
- Net Margin
- 8.52%
- ROE
- 4.62%
- ROIC
- 1.59%
Latest fiscal year · YoY change
- Revenue
- $5.33B+10.8%
- Gross Profit
- $1.73B+13.3%
- Op Income
- $182.76M
- Net Income
- $369.72M+354.0%
- EPS
- $0.18+139.4%
- OCF Growth
- +333.7%
- FCF Growth
- +502.1%
- 52W High
- $2.45
- 52W Low
- $0.90
- 50D MA
- $0.97
- 200D MA
- $1.50
- Beta
- 1.14
- RSI (14)
- 44
- Avg Volume
- 87
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Ping An Health reported 2021 revenue growth with improving business quality, while continuing to invest in its HMO/O2O/Family Doctor strategy and enterprise and insurance channels.· March 15, 2022
- 2021 revenue was RMB7.334 billion, up about 7% year on year; Medical Services revenue was RMB2.288 billion, up 8%.
- Medical Services accounted for 31.2% of revenue, up 0.3 percentage points year on year.
- Gross profit margin was 36.1% for Medical Services and 17.5% for Health Services; management said margins were pressured by strategy shifts and COVID-19.
- Registered users reached 420 million, cumulative consultations hit 1.27 billion, and paying users exceeded 38 million.
- Management said the company is still in the early stages of its strategic upgrade, so investment will continue, but large upfront investments have already been made and future spending should ease.
2021 total revenue was RMB7.334 billion, up about 7% year on year. Medical Services revenue was RMB2.288 billion, up 8% year on year, and represented 31.2% of total revenue, up 0.3 percentage points. The Medical Services gross profit margin was 36.1%, while the Health Services gross profit margin was 17.5%. Management also said expense control improved, with a 10% year-on-year profit reduction in the second half and a 7% month-on-month decrease in the expense ratio in the second half. Looking ahead, the company did not give formal numerical guidance, but said it will continue investing in the HMO Plus, O2O Plus and Family Doctor strategy, with future investment levels lower than before because major upfront spending has already been made.
Fang Weihao framed 2021 as the first year of a broader strategic upgrade, with the company shifting from volume-driven growth toward quality, compliance and more monetizable service models. He repeatedly emphasized the Family Doctor membership system as the core bridge between users, providers, insurers and enterprise customers, and described Ping An Health as a comprehensive health management solution rather than a pure online medical institution. His tone was constructive and confident, but he acknowledged the strategy is complex, long-cycle and still requires ongoing refinement.
Zang Luoqi focused on the financial mix and margin profile, noting that Medical Services revenue growth of 8% outpaced Health Services growth of 6%. She highlighted the gross profit margins of 36.1% for Medical Services and 17.5% for Health Services, and said the company kept expenses under control, with a 10% year-on-year profit reduction in the second half and a 7% month-on-month decrease in the expense ratio in the second half. In the Q&A, she also said the board believes the shares are undervalued, that current financial assets support the buyback program, and that the company has already spent more than 500 million on repurchases after the annual report.
Analysts asked whether stricter internet medical regulation would hurt the business, and management argued the policies are constructive because Ping An Health already built quality-control, real-name consultation and prescription processes, plus AI-assisted triage and review. They also said the company has 12 internet hospitals and that AI suggestions are accepted by doctors about 70% of the time, while prescriptions are verified before approval. On HMO and profitability timing, management said the HMO Plus/O2O Plus/Family Doctor strategy is a long and complex build, and although they are not giving a near-term breakeven timeline, they are confident the model can create a flywheel over time. Management also said the company intends to expand beyond Ping An Group channels to external partners such as insurance agencies, HR service providers and industrial partners.
The call showed clear evidence of scale and user engagement, including 420 million registered users, 1.27 billion consultations and more than 38 million paying users. Management believes regulatory tightening favors larger, compliant players like Ping An Health, and it has already built quality-control systems, internet hospitals and a broad doctor network to support that position. They also see long-term upside from cross-selling health services through Ping An’s insurance, enterprise and financial ecosystems.
The company is still in a heavy investment phase, and management admitted the HMO/O2O/Family Doctor buildout is long, complex and requires continued spending. Gross margin came under pressure as the company shifted away from some high-cost, low-revenue services and because of COVID-19-related impacts. Management did not provide formal forward financial guidance or a clear breakeven timeline, which leaves the pace of profit improvement uncertain.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 40.4%
- Shares Outstanding
- 2.13B
- Float Shares
- 859.94M
Held by 1 ETFs
Biggest fund positions in PANHF by dollar value.
Our PANHF coverage
Recent articles, reports, and earnings notes.
No research on PANHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PANHF report →Ping An Healthcare and Technology (OTCMKTS:PANHF) Trading Down 6.3% – What’s Next?
defenseworld.net · Jan 30
Ping An Healthcare: A Buy Considering Results Preview And Parent Stake Increase (Rating Upgrade)
seekingalpha.com · Mar 6
Ping An Health and Medtronic Form Strategic Partnership at the China International Import Expo (CIIE)
prnewswire.com · Nov 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.